New Delhi, April 27 -- While the Indian primary market may have cooled off due to a meltdown on Dalal Street this year, the top-performing debutants of 2025 have largely remained on a firm footing. T... और पढ़ें
India, April 27 -- Nicolas Pepe doesn't seem to stay single for long, and if the latest viral tweet is to be believed, the Villarreal winger has once again found himself in the spotlight. Known for hi... और पढ़ें
Mumbai, April 27 -- A sessions court in Maharashtra's Nashik district today refused to grant interim protection to Nida Khan, prime accused in the sexual harassment and religious coercion case at Tata... और पढ़ें
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... और पढ़ें
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... और पढ़ें
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... और पढ़ें
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... और पढ़ें
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... और पढ़ें
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... और पढ़ें
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... और पढ़ें